| 國立成功大學 |
2023 |
Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan
|
Liu, P.Y.-T.;Lin, F.-J.;Yeh, C.-F.;Hsiao, Y.-C.;Hsuan, C.-F.;Chang, W.-T.;Kao, H.-L.;Jeng, Jeng J.-S.;Wu, Y.-W.;Hsieh, I.-C.;Fang, C.-C.;Wang, K.-Y.;Chang, K.-C.;Lin, T.-H.;Sheu, W.H.-H.;Li, Y.-H.;Yin, W.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C. |
| 臺大學術典藏 |
2022-09-19T03:16:39Z |
Reimbursement Lag of New Drugs Under Taiwan's National Health Insurance System Compared With United Kingdom, Canada, Australia, Japan, and South Korea
|
Shih Y.-R.; Liao K.-H.; Chen Y.-H.; Lin F.-J.; FEI-YUAN HSIAO |
| 臺大學術典藏 |
2022-09-19T03:16:36Z |
Nationwide trends in incidence, healthcare utilization, and mortality in hospitalized heart failure patients in Taiwan
|
Wang T.-D.; Huang S.-T.; Wang C.-Y.; Lin F.-J.; Chen H.-M.; FEI-YUAN HSIAO |
| 臺大學術典藏 |
2022-09-15T02:44:08Z |
Amantadine treatment and delayed onset of levodopa-induced dyskinesia in patients with early Parkinson's disease
|
Wang C.-C.; Wu T.-L.; Lin F.-J.; Tai C.-H.; CHIN-HSIEN LIN; Wu R.-M. |
| 臺大學術典藏 |
2022-09-06T02:41:53Z |
Comparing Cardiovascular Safety of Febuxostat and Allopurinol in the Real World: A Population-Based Cohort Study
|
Su C.-Y.; Shen L.-J.; Hsieh S.-C.; LIAN-YU LIN; Lin F.-J. |
| 臺大學術典藏 |
2022-09-06T01:29:26Z |
The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
|
Hsuan C.-F.; Lin F.-J.; Lee T.-L.; Yang K.-C.; Tseng W.-K.; Wu Y.-W.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Chang W.-T.; Lee Y.-H.; Chen J.-W.; Sheu H.-H.; Hsieh I.-C.; Chen Y.-S.; Liu M.-E.; Chen C.-H.; Lin L.-Y.; Yeh H.-I.; Sung S.-H.; Liu P.-Y.; Wu I.-H.; Wang Z.-H.; Chiu K.-M.; Kuo C.-T.; Wang T.-D.; Hung C.-L.; Wang C.-H.; Wang C.-C.; Wang C.-Y.; JIANN-SHING JENG; Lin T.-H.; Kao H.-L.; Chu P.-H.; Lin F.-J.; Chen Z.-C.; Chang K.-C.; Yin W.-H.; Tseng W.-K.; The Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2022-07-25T06:31:24Z |
The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
|
Hsuan C.-F.; Lin F.-J.; Lee T.-L.; KAI-CHIEN YANG; Tseng W.-K.; Wu Y.-W.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Chang W.-T.; Lee Y.-H.; Sheu H.-H.; Hsieh I.-C.; Chen Y.-S.; Liu M.-E.; Chen C.-H.; Lin L.-Y.; Sung S.-H.; Liu P.-Y.; Wu I.-H.; Wang Z.-H.; Chiu K.-M.; Kuo C.-T.; Wang T.-D.; Hung C.-L.; Wang C.-H.; Wang C.-C.; Wang C.-Y.; Jeng J.-S.; Lin T.-H.; Kao H.-L.; Chu P.-H.; Chen Z.-C.; Chang K.-C.; The Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2022-06-24T02:33:28Z |
The waist-to-body mass index ratio as an anthropometric predictor for cardiovascular outcome in subjects with established atherosclerotic cardiovascular disease
|
Hsuan C.-F.; Lin F.-J.; Lee T.-L.; Yang K.-C.; Tseng W.-K.; Wu Y.-W.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; Chang W.-T.; Lee Y.-H.; Sheu H.-H.; Hsieh I.-C.; Chen Y.-S.; Liu M.-E.; Chen C.-H.; Lin L.-Y.; Sung S.-H.; Liu P.-Y.; Wu I.-H.; Wang Z.-H.; Chiu K.-M.; Kuo C.-T.; Wang T.-D.; Hung C.-L.; Wang C.-H.; Wang C.-C.; CHIH-YUAN WANG; Jeng J.-S.; Lin T.-H.; Kao H.-L.; Chu P.-H.; Chen Z.-C.; Chang K.-C.; The Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2022-05-13T08:04:09Z |
Nephrotoxicity of teicoplanin-based combination therapy: Focus on piperacillin/tazobactam and other anti-pseudomonal β-lactams
|
Tai C.-H.; Shao C.-H.; Wang C.-C.; Lin F.-J.; JANN-TAY WANG; Wu C.-C. |
| 臺大學術典藏 |
2022-05-13T08:04:02Z |
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
|
Shao C.-H.; Tai C.-H.; Lin F.-J.; Wu C.-C.; JANN-TAY WANG; Wang C.-C. |
